
|Articles|February 4, 2019
IQVIA Launches IQVIA Biotech
Advertisement
IQVIA announced the launch of IQVIA Biotech and its new approach to delivering clinical and commercial solutions for small biotech and biopharma companies. The suite delivers operating proceudres, specialized teams, and servies to life sciences in achieving drug development and commercialization goals. IQVIA Biotech works from initial planning to trial design and implementation to market launch and commercialization.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
4
FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies
5





